Neuroepithelioma  >>  ispinesib (SB-715992)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ispinesib (SB-715992) / Cytokinetics
NCT00095953: SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Completed
2
17
Canada
ispinesib
NCIC Clinical Trials Group, National Cancer Institute (NCI)
Melanoma (Skin)
09/06
09/08

Download Options